Efficacy and safety of Pegasys combined with adefovir in the treatment of chronic hepatitis B with HBeAg(+).

Trial Profile

Efficacy and safety of Pegasys combined with adefovir in the treatment of chronic hepatitis B with HBeAg(+).

Recruiting
Phase of Trial: Phase III

Latest Information Update: 21 May 2012

At a glance

  • Drugs Adefovir (Primary) ; Peginterferon alfa-2a (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Last checked against Chinese Clinical Trial Register record.
    • 21 May 2012 Planned End Date changed from 1 Dec 2012 to 31 Dec 2012 as reported by Chinese Clinical Trial Register record.
    • 16 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top